Japan, July 27 -- ALEXION PHARMACEUTICALS INC has got intellectual property rights for 'ANTI-C5 ANTIBODIES HAVING IMPROVED PHARMACOKINETICS.' Other related details are as follows:

Application Number: JP,2024-011008

Category (FI): A61K39/395@D,C12N15/13,C07K16/18,C12N15/63@Z,C12N1/15,C12N1/19,A61P17/06,A61P7/06,A61P3/06,A61K39/395@N,C12N1/21,C12N5/10,A61P21/00,A61P21/04,A61P3/10,C12P21/08,A61P43/00,111,A61P29/00,101,A61P19/02,A61P13/12,A61P9/10,A61P13/02,A61P27/02,A61P25/02,A61P25/00,A61P37/02,A61P1/04,A61P25/28,A61P17/00,A61P15/06,A61P7/04,A61P7/00,A61P9/00,A61P5/14,A61P9/10,101,A61P31/04,A61P37/06

Stage: Grant (IP right granted following substantive examination.)

Filing Date: Jan. 29, 2024

Publication Date: March 19, 2024

The origina...